An Anti-Inflammatory Sterol Decreases Obesity-Related Inflammation-Induced Insulin Resistance and Metabolic Dysregulation
Figure 3
Intrasubject HbA1c changes in placebo comparisons. Bar and whisker plots of the change in HbA1c between visits for individual subjects: (a) healthy subjects from study 2100-202, (b) dyslipidemic subjects from study 2200-130, (c) impaired glucose tolerance subjects from study 3286-0102, (d) treatment-naïve type 2 diabetes patients from HE3286-0401 cohort 2, (e) type 2 diabetic patients on a stable dose of metformin from HE3286-0401 cohort 1, (f) intravisit changes for all subjects from each condition plotted on the same scale. IGT: impaired glucose tolerant, Metformin T2DM: uncontrolled type 2 diabetes mellitus participants on a stable dose of metformin.
